Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043]

Status:

Topic prioritisation

Technology type:

Medicine

Decision:

Not selected

Rationale:

Decision makers have concluded that the clear rationale to not evaluate this product is due to appropriate access to the medicine being provided by an existing NHSE clinical commissioning policy. Therefore, a NICE evaluation would not add any further value.

ID number:

12043

Project Team

Project lead

Danielle Lees

Email enquiries

If you have any queries please email topic.selection@nice.org.uk

Timeline

Key events during the development of the guidance:

For further information on how we select topics for development, please see our page about topic prioritisation